The stock of Oncimmune Holdings PLC (LON:ONC) hit a new 52-week low and has GBX 96.12 target or 11.00% below today’s GBX 108.00 share price. The 9 months bearish chart indicates high risk for the GBX 54.64 million company. The 1-year low was reported on Nov, 8 by Barchart.com. If the GBX 96.12 price target is reached, the company will be worth GBX 6.01 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. The stock closed at GBX 108 during the last session. It is down 6.00% since October 9, 2016 and is uptrending. It has outperformed by 4.04% the S&P500.
Oncimmune Holdings plc is a United Kingdom cancer detection company. The company has a market cap of 54.64 million GBP. The Firm is engaged in developing and commercializing its EarlyCDT platform technology. It currently has negative earnings. The Firm is involved in the development of tests based on the presence in the blood of autoantibodies against specific tumor associated antigens that can detect cancer till approximately four years earlier than other methods, such as a chest X-ray or spiral computed tomography (CT), and is applied to a range of tumor types.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.